GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc (NYSE:DCF) » Definitions » ROE %

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund ROE % : 19.19% (As of Feb. 2024)


View and export this data going back to 2017. Start your Free Trial

What is BNY Mellon Alcentra Global Creditome 2024 Target Term Fund ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's annualized net income for the quarter that ended in Feb. 2024 was $24.59 Mil. BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's average Total Stockholders Equity over the quarter that ended in Feb. 2024 was $128.11 Mil. Therefore, BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's annualized ROE % for the quarter that ended in Feb. 2024 was 19.19%.

The historical rank and industry rank for BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's ROE % or its related term are showing as below:

DCF' s ROE % Range Over the Past 10 Years
Min: -10.8   Med: 2.04   Max: 16.91
Current: 16.91

During the past 6 years, BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's highest ROE % was 16.91%. The lowest was -10.80%. And the median was 2.04%.

DCF's ROE % is ranked better than
85.39% of 1697 companies
in the Asset Management industry
Industry Median: 4.06 vs DCF: 16.91

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund ROE % Historical Data

The historical data trend for BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund ROE % Chart

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Annual Data
Trend Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
ROE %
Get a 7-Day Free Trial 2.04 0.45 15.59 -10.80 11.35

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Semi-Annual Data
Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -2.98 -18.90 8.26 14.58 19.19

Competitive Comparison of BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's ROE %

For the Asset Management subindustry, BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's ROE % Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's ROE % distribution charts can be found below:

* The bar in red indicates where BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's ROE % falls into.



BNY Mellon Alcentra Global Creditome 2024 Target Term Fund ROE % Calculation

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's annualized ROE % for the fiscal year that ended in Aug. 2023 is calculated as

ROE %=Net Income (A: Aug. 2023 )/( (Total Stockholders Equity (A: Aug. 2022 )+Total Stockholders Equity (A: Aug. 2023 ))/ count )
=13.713/( (118.152+123.539)/ 2 )
=13.713/120.8455
=11.35 %

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's annualized ROE % for the quarter that ended in Feb. 2024 is calculated as

ROE %=Net Income (Q: Feb. 2024 )/( (Total Stockholders Equity (Q: Aug. 2023 )+Total Stockholders Equity (Q: Feb. 2024 ))/ count )
=24.588/( (123.539+132.683)/ 2 )
=24.588/128.111
=19.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Feb. 2024) net income data. ROE % is displayed in the 30-year financial page.


BNY Mellon Alcentra Global Creditome 2024 Target Term Fund  (NYSE:DCF) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Feb. 2024 )
=Net Income/Total Stockholders Equity
=24.588/128.111
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(24.588 / 25.214)*(25.214 / 182.593)*(182.593 / 128.111)
=Net Margin %*Asset Turnover*Equity Multiplier
=97.52 %*0.1381*1.4253
=ROA %*Equity Multiplier
=13.47 %*1.4253
=19.19 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Feb. 2024 )
=Net Income/Total Stockholders Equity
=24.588/128.111
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (24.588 / 24.588) * (24.588 / 25.214) * (25.214 / 182.593) * (182.593 / 128.111)
= Tax Burden * Pretax Margin % * Asset Turnover * Equity Multiplier
= 1 * 97.52 % * 0.1381 * 1.4253
=19.19 %

Note: The net income data used here is two times the semi-annual (Feb. 2024) net income data. The Revenue data used here is two times the semi-annual (Feb. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


BNY Mellon Alcentra Global Creditome 2024 Target Term Fund ROE % Related Terms

Thank you for viewing the detailed overview of BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Business Description

Traded in Other Exchanges
N/A
Address
c/o BNY Mellon Investment Adviser, Inc., 240 Greenwich Street, New York, NY, USA, 10286
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc is a diversified closed-end management investment company. Its investment objectives are to seek high current income and to return at least the Fund's original NAV to holders of record of common shares on or about the termination date.
Executives
Bushra Mannan other: Director of BNYMIA (1) C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Irene Papadoulis other: Director of BNYMIA (1) C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Ping Jiang other: Dir. of Invest. Oversight (1) C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Bradley J Skapyak officer: President 200 PARK AVENUE, NEW YORK NY 10166
Joseph Martella officer: VP C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10288
Daniel Goldstein officer: VP 240 GREENWICH STREET, NEW YORK NY 10286
Robert J. Pomeroy officer: VP; Investment Adviser C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Vinay Patel other: Head of Finance of Sub-Adviser 200 PARK AVE, NEW YORK CITY NY 10166
Alcentra Ny, Llc other: Sub-Adviser 200 PARK AVENUE, 7TH FLOOR, NEW YORK NY 10166
Brandon Chao other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Laurence Raven other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Ross Curran other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Cathy Bevan other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Daire Wheeler other: Portfolio Mgr of Sub-Adviser 200 PARK AVENUE, NEW YORK CITY NY 10166
Eric Larsson other: Portfolio Mgr of Sub-Adviser C/O ALCENTRA NY LLC, 200 PARK AVENUE, NEW YORK CITY NY 10166